Mir I. I. Wahed

Bisoprolol Improves Survival in Rats with Heart Failure

Masahiro Ito, Kenichi Watanabe, M. Kodama, 2001, Journal of cardiovascular pharmacology.

Betaxolol Improves the Survival Rate and Changes Natriuretic Peptide Expression in Rats with Heart Failure

Tadashi Yamamoto, K. Yamaguchi, Kenichi Watanabe, 2003, Journal of Cardiovascular Pharmacology.

Contribution of Sympathetic Nervous System Activity during Administration of Carvedilol in Rats with Dilated Cardiomyopathy

M. Miyazaki, K. Yamaguchi, Kenichi Watanabe, 2003, Journal of cardiovascular pharmacology.

Inhibition of Progression of Heart Failure and Expression of TGF‐&bgr;1 mRNA in Rats with Heart Failure by the ACE Inhibitor Quinapril

Tadashi Yamamoto, Kenichi Watanabe, M. Kodama, 2001, Journal of cardiovascular pharmacology.

Hemodynamic Effects of Carvedilol Infusion and the Contribution of the Sympathetic Nervous System in Rats with Heart Failure

M. Miyazaki, K. Yamaguchi, Kenichi Watanabe, 2004, Pharmacology.

Effects of angiotensin-II receptor blocker candesartan cilexetil in rats with dilated cardiomyopathy

Kenichi Watanabe, M. Kodama, Y. Aizawa, 2005, Molecular and Cellular Biochemistry.

Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.

Kenichi Watanabe, M. Kodama, Y. Aizawa, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparative Effects of Perindopril with Enalapril in Rats with Dilated Cardiomyopathy

K. Yamaguchi, Kenichi Watanabe, M. Kodama, 2003, Journal of cardiovascular pharmacology.

Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis

Tadashi Yamamoto, Kenichi Watanabe, M. Kodama, 2003, Molecular and Cellular Biochemistry.

Comparative Effects of Angiotensin II Receptor Blockade (Candesartan) with Angiotensin‐Converting Enzyme Inhibitor (Quinapril) in Rats with Dilated Cardiomyopathy

Tadashi Yamamoto, K. Yamaguchi, Kenichi Watanabe, 2003, Journal of cardiovascular pharmacology.